Literature DB >> 28695237

Cytopathology of pericardial effusions : Experience from a tertiary center of cardiology.

C Gecmen1, G G Gecmen2, D Ece2, M Kahyaoğlu2, A Kalayci2, C Y Karabay2, O Candan2, M E Isik2, F Yilmaz2, O Akgun2, M Celik2, I A Izgi2, C Kirma2, S Keser2.   

Abstract

BACKGROUND: Pericardial effusion (PE) is a common clinical condition that can develop as a result of systemic or cardiac diseases. Here, we report the results of cytology for patients who underwent pericardiocentesis for PE.
METHODS: The study comprised 283 patients who underwent primary percutaneous pericardiocentesis between 2007 and 2016. The mean age of the patients was 60.0 ± 16.6 years; 162 (57.2%) were male and 121 (42.8%) were female. The presence of reactive mesothelial cells, acute and chronic inflammatory cells, and/or blood without evidence of malignant cells was considered as benign. The presence of malignant cells with/without reactive mesothelial cells, inflammatory cells, and/or blood was considered as malignant.
RESULTS: The vast majority of PE specimens (219 cases; 77.4%) were classified as benign. Only 20 cases (7.1%) were classified as atypical, and malignant cells were present in the PE specimens of 44 cases (15.5%). The most common diagnosis was benign PE. The most commonly encountered malignancy was lung cancer. The rate of malignancy was 1.9% in the serous group and 24% in the hemorrhagic group, which was statistically significant.
CONCLUSION: Benign PE was the most frequent cytological diagnosis in our study. Chronic nonspecific pericarditis was the most frequent type of pericarditis in the benign PE group, while lung adenocarcinoma was the most frequent malignancy in the malignant PE group. The rate of malignancy was significantly higher in the hemorrhagic group than in the serous group.

Entities:  

Keywords:  Cytology; Hemopericardium; Pathology; Pericardiocentesis; Pericarditis

Mesh:

Year:  2017        PMID: 28695237     DOI: 10.1007/s00059-017-4596-8

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  31 in total

Review 1.  Acute cardiac tamponade.

Authors:  David H Spodick
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

2.  Tailoring diagnosis and management of pericardial disease to the epidemiological setting.

Authors:  Faisal F Syed; Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 3.  Tumors of the heart and pericardium.

Authors:  G Wilding; H L Green; D L Longo; W J Urba
Journal:  Cancer Treat Rev       Date:  1988-09       Impact factor: 12.111

4.  [Cholesterol pericarditis associated with rheumatoid arthritis].

Authors:  B Knobel; P Rosman
Journal:  Harefuah       Date:  2001-01

5.  The usefulness of diagnostic tests on pericardial fluid.

Authors:  D G Meyers; R E Meyers; T W Prendergast
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

6.  Primary malignant mesothelioma of the pericardium.

Authors:  Junaid Patel; Mary N Sheppard
Journal:  Cardiovasc Pathol       Date:  2010-02-08       Impact factor: 2.185

7.  Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion.

Authors:  Konstantinos Karatolios; Sabine Pankuweit; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

8.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Yehuda Adler; Philippe Charron; Massimo Imazio; Luigi Badano; Gonzalo Barón-Esquivias; Jan Bogaert; Antonio Brucato; Pascal Gueret; Karin Klingel; Christos Lionis; Bernhard Maisch; Bongani Mayosi; Alain Pavie; Arsen D Ristic; Manel Sabaté Tenas; Petar Seferovic; Karl Swedberg; Witold Tomkowski
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period.

Authors:  Ema A Dragoescu; Lina Liu
Journal:  Cancer Cytopathol       Date:  2013-01-29       Impact factor: 5.284

10.  Indicators of poor prognosis of acute pericarditis.

Authors:  Massimo Imazio; Enrico Cecchi; Brunella Demichelis; Salvatore Ierna; Daniela Demarie; Aldo Ghisio; Franco Pomari; Luisella Coda; Riccardo Belli; Rita Trinchero
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

View more
  4 in total

Review 1.  Pericardial Disease Associated with Malignancy.

Authors:  Ryan Schusler; Shari L Meyerson
Journal:  Curr Cardiol Rep       Date:  2018-08-20       Impact factor: 2.931

2.  Constrictive pericarditis caused by pericardial metastasis from esophageal squamous cell carcinoma: a case report.

Authors:  Takayoshi Kishino; Kensuke Kumamoto; Hiroyuki Matsukawa; Akihiro Kondo; Yasuhisa Ando; Jun Uemura; Hironobu Suto; Eisuke Asano; Minoru Oshima; Yoichi Chiba; Masaki Ueno; Sayako Nakagawa; Shohei Kitamoto; Yoichi Yamashita; Taiko Horii; Keiichi Okano
Journal:  Int Cancer Conf J       Date:  2022-03-15

Review 3.  The Value of Cytology in the Evaluation of Malignant Pericardial Effusions: A Systematic Review.

Authors:  Ranim Shartouni; Roy Shartouni; Maryam Mahmoodi; Ilias P Nikas
Journal:  Diagnostics (Basel)       Date:  2022-02-01

4.  Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.

Authors:  Sachin Kolte; Sufian Zaheer; Durre Aden; Sunil Ranga
Journal:  Cytojournal       Date:  2022-09-05       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.